5-178994812-ACAGGCCGCCCAGCGT-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM4PP3
The NM_000843.4(GRM6):βc.118_132delβ(p.Thr40_Leu44del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000228 in 1,274,676 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.0000067 ( 0 hom., cov: 33)
Exomes π: 0.000025 ( 0 hom. )
Consequence
GRM6
NM_000843.4 inframe_deletion
NM_000843.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.58
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_000843.4.
PP3
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRM6 | NM_000843.4 | c.118_132del | p.Thr40_Leu44del | inframe_deletion | 2/11 | ENST00000517717.3 | NP_000834.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRM6 | ENST00000517717.3 | c.118_132del | p.Thr40_Leu44del | inframe_deletion | 2/11 | 5 | NM_000843.4 | ENSP00000430767 | P1 | |
GRM6 | ENST00000231188.9 | c.118_132del | p.Thr40_Leu44del | inframe_deletion | 1/10 | 2 | ENSP00000231188 | P1 | ||
GRM6 | ENST00000650031.1 | c.118_132del | p.Thr40_Leu44del | inframe_deletion | 3/12 | ENSP00000497110 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000670 AC: 1AN: 149298Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
149298
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000249 AC: 28AN: 1125378Hom.: 0 AF XY: 0.0000274 AC XY: 15AN XY: 546668
GnomAD4 exome
AF:
AC:
28
AN:
1125378
Hom.:
AF XY:
AC XY:
15
AN XY:
546668
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000670 AC: 1AN: 149298Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 72808
GnomAD4 genome
AF:
AC:
1
AN:
149298
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
72808
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital stationary night blindness Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | This variant, c.118_132del, results in the deletion of 5 amino acid(s) of the GRM6 protein (p.Thr40_Leu44del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with congenital stationary night blindness (PMID: 28041643). ClinVar contains an entry for this variant (Variation ID: 437969). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at